# Preliminary Study of CXCL3 As a Biomarker of Diabetic Kidney Disease

> **NCT06639529** · NA · COMPLETED · sponsor: **The First Hospital of Jilin University** · enrollment: 120 (actual)

## Conditions studied

- Diabetic Kidney Disease (DKD)

## Interventions

- **DIAGNOSTIC_TEST:** Tests of the expression of CXCL3 in various tissues

## Key facts

- **NCT ID:** NCT06639529
- **Lead sponsor:** The First Hospital of Jilin University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-06-10
- **Primary completion:** 2024-07-30
- **Final completion:** 2024-07-30
- **Target enrollment:** 120 (ACTUAL)
- **Last updated:** 2024-10-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06639529

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06639529, "Preliminary Study of CXCL3 As a Biomarker of Diabetic Kidney Disease". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06639529. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*